PortfoliosLab logo
SHW vs. PFE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SHW and PFE is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

SHW vs. PFE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Sherwin-Williams Company (SHW) and Pfizer Inc. (PFE). The values are adjusted to include any dividend payments, if applicable.

0.00%200.00%400.00%600.00%800.00%December2025FebruaryMarchAprilMay
751.12%
66.43%
SHW
PFE

Key characteristics

Sharpe Ratio

SHW:

0.48

PFE:

-0.62

Sortino Ratio

SHW:

0.97

PFE:

-0.58

Omega Ratio

SHW:

1.12

PFE:

0.93

Calmar Ratio

SHW:

0.62

PFE:

-0.21

Martin Ratio

SHW:

1.49

PFE:

-0.91

Ulcer Index

SHW:

8.85%

PFE:

13.28%

Daily Std Dev

SHW:

24.45%

PFE:

23.81%

Max Drawdown

SHW:

-52.03%

PFE:

-58.96%

Current Drawdown

SHW:

-11.35%

PFE:

-56.34%

Fundamentals

Market Cap

SHW:

$90.13B

PFE:

$134.92B

EPS

SHW:

$10.57

PFE:

$1.41

PE Ratio

SHW:

34.02

PFE:

16.87

PEG Ratio

SHW:

3.64

PFE:

0.61

PS Ratio

SHW:

3.91

PFE:

2.17

PB Ratio

SHW:

21.82

PFE:

1.56

Total Revenue (TTM)

SHW:

$23.04B

PFE:

$62.46B

Gross Profit (TTM)

SHW:

$11.22B

PFE:

$42.09B

EBITDA (TTM)

SHW:

$4.47B

PFE:

$16.71B

Returns By Period

In the year-to-date period, SHW achieves a 4.24% return, which is significantly higher than PFE's -11.99% return. Over the past 10 years, SHW has outperformed PFE with an annualized return of 15.08%, while PFE has yielded a comparatively lower 0.57% annualized return.


SHW

YTD

4.24%

1M

12.78%

6M

-7.55%

1Y

11.76%

5Y*

15.11%

10Y*

15.08%

PFE

YTD

-11.99%

1M

5.17%

6M

-13.65%

1Y

-13.66%

5Y*

-4.28%

10Y*

0.57%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SHW vs. PFE — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SHW
The Risk-Adjusted Performance Rank of SHW is 6969
Overall Rank
The Sharpe Ratio Rank of SHW is 7070
Sharpe Ratio Rank
The Sortino Ratio Rank of SHW is 6565
Sortino Ratio Rank
The Omega Ratio Rank of SHW is 6262
Omega Ratio Rank
The Calmar Ratio Rank of SHW is 7676
Calmar Ratio Rank
The Martin Ratio Rank of SHW is 6969
Martin Ratio Rank

PFE
The Risk-Adjusted Performance Rank of PFE is 2727
Overall Rank
The Sharpe Ratio Rank of PFE is 1818
Sharpe Ratio Rank
The Sortino Ratio Rank of PFE is 2222
Sortino Ratio Rank
The Omega Ratio Rank of PFE is 2424
Omega Ratio Rank
The Calmar Ratio Rank of PFE is 3939
Calmar Ratio Rank
The Martin Ratio Rank of PFE is 3131
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SHW vs. PFE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for The Sherwin-Williams Company (SHW) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current SHW Sharpe Ratio is 0.48, which is higher than the PFE Sharpe Ratio of -0.62. The chart below compares the historical Sharpe Ratios of SHW and PFE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2025FebruaryMarchAprilMay
0.46
-0.62
SHW
PFE

Dividends

SHW vs. PFE - Dividend Comparison

SHW's dividend yield for the trailing twelve months is around 0.83%, less than PFE's 9.23% yield.


TTM20242023202220212020201920182017201620152014
SHW
The Sherwin-Williams Company
0.83%0.84%0.78%1.01%0.62%0.73%0.77%0.87%0.83%1.25%1.03%0.84%
PFE
Pfizer Inc.
9.23%6.33%5.70%3.12%2.64%3.92%3.68%3.12%3.54%3.70%3.48%3.34%

Drawdowns

SHW vs. PFE - Drawdown Comparison

The maximum SHW drawdown since its inception was -52.03%, smaller than the maximum PFE drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for SHW and PFE. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%December2025FebruaryMarchAprilMay
-11.35%
-56.34%
SHW
PFE

Volatility

SHW vs. PFE - Volatility Comparison

The current volatility for The Sherwin-Williams Company (SHW) is 8.33%, while Pfizer Inc. (PFE) has a volatility of 8.97%. This indicates that SHW experiences smaller price fluctuations and is considered to be less risky than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%December2025FebruaryMarchAprilMay
8.33%
8.97%
SHW
PFE

Financials

SHW vs. PFE - Financials Comparison

This section allows you to compare key financial metrics between The Sherwin-Williams Company and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


5.00B10.00B15.00B20.00B25.00B20212022202320242025
5.31B
13.72B
(SHW) Total Revenue
(PFE) Total Revenue
Values in USD except per share items

SHW vs. PFE - Profitability Comparison

The chart below illustrates the profitability comparison between The Sherwin-Williams Company and Pfizer Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%80.0%20212022202320242025
48.2%
79.3%
(SHW) Gross Margin
(PFE) Gross Margin
SHW - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, The Sherwin-Williams Company reported a gross profit of 2.56B and revenue of 5.31B. Therefore, the gross margin over that period was 48.2%.

PFE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a gross profit of 10.87B and revenue of 13.72B. Therefore, the gross margin over that period was 79.3%.

SHW - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, The Sherwin-Williams Company reported an operating income of 765.30M and revenue of 5.31B, resulting in an operating margin of 14.4%.

PFE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported an operating income of 2.79B and revenue of 13.72B, resulting in an operating margin of 20.3%.

SHW - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, The Sherwin-Williams Company reported a net income of 503.90M and revenue of 5.31B, resulting in a net margin of 9.5%.

PFE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a net income of 2.97B and revenue of 13.72B, resulting in a net margin of 21.6%.